Genentech announces results of IMspire150 study in BRAF V600 mutation-positive advanced melanoma

Genentech announces results of IMspire150 study in BRAF V600 mutation-positive advanced melanoma. Photo: courtesy of F. Hoffmann-La Roche Ltd.